3Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005; 44: 1282-1286.
4Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2005; 17: 701-706.
5Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
7American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
8Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, et al. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/ dermatomyositis. Lung 2009; 187:201-206.
9Ye S, Chen XX, Lu XY, Wu ME Deng Y, Huang WQ, et al. Adult clinically amyopathic derrnatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. CIin Rheumatol 2007; 26: 1647-1654.
1Au K,Khanna D,Clements PJ,et al.Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lungdisease:lessons from clinical trials[J].Curr Rheumatol Rep,2009,11(2):111-119.
2Tyndall AJ,Bannert B,Vonk M,et al.Causes and risk factorsfordeath in systemic sclerosis:a study from the EULAR Sclero-dermaTrials and Research(EUSTAR)database[J].Ann RheumDis,2010,69(10):1809-1815.
3No authors listed.Preliminary criteria for the classification of sys-temic sclerosis(scleroderma).Subcommittee for scleroderma crite-ria of the American Rheumatism Association Diagnostic and Thera-peutic Criteria Committee[J].Arthritis Rheum,1980,23(5):581-590.
4White B.Interstitial lung disease in scleroderma[J].Rheum DisClin North Am,2003,29(2):371-390.
5Van der Kamp R,Tak PP,Jansen HM,et al.Interstitial lung dis-ease as the first manifestation of systemic sclerosis[J].Neth JMed,2007,65(10):390-394.
6Hamaguchi Y.Autoantibody profiles in systemic sclerosis:predic-tive value for clinical evaluation and prognosis[J].J Dermatol,2010,37(1):42-53.
7Raghu G,Mageto YN,Lockhart D,et al.The accuracy of the clini-cal diagnosis of new-onset idiopathic pulmonary fibrosis and otherinterstitial lung disease:a prospective study[J].Chest,1999,116(5):1168-1174.
8Behr J,Furst DE.Pulmonary function tests[J].Rheumatology,2008,47(5):65-67.
9Chang JA,Curtis JR,Patrick DL,et al.Assessment of health relat-ed quality of life in patients with interstitial lung disease[J].Chest,1999,116(5):1175-1182.
